Is antenatal steroid treatment effective in preterm IUGR fetuses?

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 10, 2009, Pages 1068-1073

  Torrance, Helen L ^a,b   Derks, Jan B ^a   Scherjon, Sicco A ^c   Wijnberger, Lia D ^c   Visser, Gerard H A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antenatal steroid treatment; Intrauterine growth restriction; Neonatal morbidity; Neurodevelopmental outcome; Small for gestational age

Indexed keywords

STEROID;

BRAIN HEMORRHAGE; CLINICAL TRIAL; DISABILITY; DOPPLER FLOWMETRY; FETUS LUNG MATURATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MORBIDITY; NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; PLACENTA INSUFFICIENCY; PRENATAL PERIOD; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SMALL FOR DATE INFANT; UMBILICAL ARTERY;

ADRENAL CORTEX HORMONES; ANIMALS; ENTEROCOLITIS, NECROTIZING; FETAL GROWTH RETARDATION; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, SMALL FOR GESTATIONAL AGE; LEUKOMALACIA, PERIVENTRICULAR; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 70350628657     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340903176784     Document Type: Review

References (36)

1. Cunningham FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC. Williams obstetrics. London: Prentice-Hall; 1993.
2. Economides DL, Nicolaides KH, Linton EA, Perry LA, Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther. 1988;/ 3:/158-64.
3. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, et al. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: An analysis of possible mechanisms. J Clin Endocrinol Metab. 2001;/86:/ 4979-83.
4. Piazze JJ, Maranghi L, Nigro G, Rizzo G, Cosmi EV, Anceschi MM. The effect of glucocorticoid therapy on fetal lung maturity indices in hypertensive pregnancies. Obstet Gynecol. 1998;/92:/220-5.
5. Soregaroli M, Bonera R, Danti L, Dinolfo D, Taddei F, Valcamonico A, et al. Prognostic role of umbilical artery Doppler velocimetry in growth-restricted fetuses. J Matern Fetal Neonatal Med. 2002;/11:/199-203.
6. Sterne G, Shields LE, Dubinsky TJ. Abnormal fetal cerebral and umbilical Doppler measurements in fetuses with intrauterine growth restriction predicts the severity of perinatal morbidity. J Clin Ultrasound. 2001;/29:/146-51.
7. Torrance HL, Mulder EJ, Brouwers HA, van Bel F, Visser GH. Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and/or maternal hypertension. J Matern Fetal Neonatal Med. 2007;/20:/613-21.
8. Torrance HL, Voorbij HA, Wijnberger LD, van Bel F, Visser GH. Lung maturation in small for gestational age fetuses from pregnancies complicated by placental insufficiency or maternal hypertension. Early Hum Dev. 2008;/84:/465-9.
9. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005;/365:/1856-62.
10. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ. 2005;331:665-671.
11. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995;273:413-8.
12. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2000;2:CD000065.
13. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:CD004454.
14. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;/50:/ 515-25.
15. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol. 1999;/94:/213-8.
16. Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol. 1998;/178:/880-5.
17. Miller SL, Chai M, Loose J, Castillo-Melendez M, Walker DW, Jenkin G, et al. The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus. Endocrinology. 2007;/148:/1288-95.
18. Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998;/95:/115-28.
19. Wijnberger LD, Bilardo CM, Hecher K, Stigter RH, Visser GH. Effect of antenatal glucocorticoid therapy on arterial and venous blood flow velocity waveforms in severely growthrestricted fetuses. Ultrasound Obstet Gynecol. 2004;/23:/ 584-9.
20. Simchen MJ, Alkazaleh F, Adamson SL, Windrim R, Telford J, Beyene J, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2004;/190:/296-304.
21. Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet. 1999;/ 353:/1404-7.
22. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med. 1999;/341:/1190-6.
23. Soothill PW, Bobrow CS, Holmes R. Small for gestational age is not a diagnosis. Ultrasound Obstet Gynecol. 1999;/13:/ 225-8.
24. Burke G, Stuart B, Crowley P, Scanaill SN, Drumm J. Is intrauterine growth retardation with normal umbilical artery blood flow a benign condition? BMJ. 1990;/300:/1044-5.
25. Schaap AH, Wolf H, Bruinse HW, Smolders-De Haas H, Van EI, Treffers PE. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants. Obstet Gynecol. 2001;/ 97:/954-60.
26. van Stralen G, van der Bos J, Lopriore E, te Pas AB, Bloemenkamp KW, Walther FJ, et al. No benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: A case-control study. Early Hum Dev. 2009 Apr;85(4):253-7. Epub 2008 Nov 22.
27. Spinillo A, Capuzzo E, Ometto A, Stronati M, Baltaro F, Iasci A. Value of antenatal corticosteroid therapy in preterm birth. Early Hum Dev. 1995;/42:/37-47.
28. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol. 2000;/182:/198-206.
29. Elimian A, Verma U, Canterino J, Shah J, Visintainer P, Tejani N. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol. 1999;/93:/174-9.
30. Ley D, Wide-Swensson D, Lindroth M, Svenningsen N, Marsal K. Respiratory distress syndrome in infants with impaired intrauterine growth. Acta Paediatr. 1997;/86:/ 1090-6.
31. Spinillo A, Viazzo F, Colleoni R, Chiara A, Maria CR, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol. 2004;/ 191:/217-24.
32. Wapner RJ, Sorokin Y, Mele L, Johnson F, Dudley DJ, Spong CY, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;/357:/1190-8.
33. Gould JB, Gluck L, Kulovich MV. The relationship between accelerated pulmonary maturity and accelerated neurological maturity in certain chronically stressed pregnancies. Am J Obstet Gynecol. 1977;/127:/181-6.
34. Torrance HL, Krediet TG, Vreman HJ, Visser GH, van Bel F. Oxidative stress and proinflammatory cytokine levels are increased in premature neonates of preeclamptic mothers with HELLP syndrome. Neonatology. 2008;/94:/138-42.
35. Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol. 1999;/180:/1283-8.
36. Schutte MF. De waarde van corticosteroiden en thyroxinestimulatie bij groeivertraging [The value of corticosteroids and thyroxin stimulation in growth restriction]. In: Foetale aspecten van groeivertraging [Fetal aspects of growth restriction] (in Dutch). Amsterdam, Noord-Holland, the Netherlands: Amsterdam University Press, 1992. pp. 92-8.